3,3-Diphenylpropylamine - CAS 5586-73-2
Catalog: |
BB029205 |
Product Name: |
3,3-Diphenylpropylamine |
CAS: |
5586-73-2 |
Synonyms: |
Propylamine, 3,3-diphenyl- |
IUPAC Name: | 3,3-diphenylpropan-1-amine |
Description: | 3,3-Diphenylpropylamine is a metabolite of Prenylamine. It showed antiextensor effects as well as neuroexcitatory effects and antagonized barbital-induced loss of the righting reflex. |
Molecular Weight: | 211.30 |
Molecular Formula: | C15H17N |
Canonical SMILES: | C1=CC=C(C=C1)C(CCN)C2=CC=CC=C2 |
InChI: | InChI=1S/C15H17N/c16-12-11-15(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-10,15H,11-12,16H2 |
InChI Key: | KISZTEOELCMZPY-UHFFFAOYSA-N |
Boiling Point: | 331.9 °C at 760 mmHg |
Purity: | 97 % |
Density: | 1.024 g/cm3 |
Appearance: | Clear yellow liquid after melting |
LogP: | 3.86760 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2020237167-A1 | Inhibitor of mnk for the treatment of neuropathic pain | 20190523 |
WO-2020222892-A1 | Treatment of headache using anti-cgrp antibodies | 20190502 |
WO-2020201771-A1 | New pharmaceutical compositions | 20190404 |
EP-3698776-A1 | Tamper-resistant dosage form with immediate release and resistance against solvent extraction | 20190219 |
WO-2020167927-A1 | Antibodies to cell adhesion molecule-related/down-regulated by oncogenes (cdon) and uses thereof | 20190215 |
PMID | Publication Date | Title | Journal |
22786790 | 20120901 | Identification and characterization of urinary prenylamine metabolites by means of liquid chromatography-tandem mass spectrometry | Drug testing and analysis |
19700330 | 20090915 | Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity | Bioorganic & medicinal chemistry |
12657914 | 20030401 | Chiral analysis of d- and l-modafinil in human serum: application to human pharmacokinetic studies | Therapeutic drug monitoring |
Complexity: | 160 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 211.136099547 |
Formal Charge: | 0 |
Heavy Atom Count: | 16 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 211.136099547 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 26 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Nitrogen Compounds
Customers Also Viewed
-
[7310-97-6]
2,5-Dimethoxybenzene-1,4-dicarboxaldehyde
-
[64096-87-3]
Tetrahydro-2H-thiopyran-4-carboxylic Acid 1,1-Dioxide
-
[6313-33-3]
Formamidine hydrochloride
-
[63089-56-5]
4-Amino-1,2,3,5,6,7-hexahydro-s-indacene
-
[627-67-8]
3-Methyl-1-nitrobutane
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
INDUSTRY LEADERS TRUST OUR PRODUCTS